BOAI NKY Medical Holdings Ltd. (abbreviated as NKY), is listed on ChiNext with stock code 300109. The main businesses of NKY are precision medicine and fine chemical. Precision medicine covers early cancer screening which majorly based on gene sequencing platform, molecular diagnosis, personalized medicine services, etc. As of fine chemical, NKY is the third largest PVP manufacturer and the second largest PVM/MA manufacturer in the world.
NKY has a highly internationalized team, it already set up branches in US, Germany, Sweden, Japan. NKY welcomes foreign customers and peers to communicate with us, NKY further expects a long-term win-win cooperation.